IceCure Stock Drops Before The Bell As Nasdaq’s $1 Clock Ticks
IceCure Medical Ltd shares slipped in early U.S. pre-market trading on Tuesday, leaving the Nasdaq-listed medical device maker near 20 cents and still well below the exchange’s $1 minimum bid threshold. The stock last traded at $0.2011, down 1.9 cents, or about 8.6%, from its previous close. That is why the move matters now. IceCure said in May it received a second 180-day period, until Nov. 9, 2026, to regain compliance with Nasdaq’s minimum bid price rule. The company said it would need its closing bid price — the price buyers are willing to pay — to stay at or above $1 for at least 10 straight business days, and said a reverse split, which consolidates shares to lift the